Outcomes and costs of open and endovascular revascularisation for chronic limb ischaemia in an Australian cohort

Smith, Samuel L., Norman, Richard, Moxon, Joseph V., Velu, Ramesh, Quigley, Frank, and Golledge, Jonathan (2021) Outcomes and costs of open and endovascular revascularisation for chronic limb ischaemia in an Australian cohort. Heart, Lung and Circulation, 30 (10). pp. 1552-1561.

[img] PDF (Published Version) - Published Version
Restricted to Repository staff only

View at Publisher Website: https://doi.org/10.1016/j.hlc.2021.04.01...


Objective: The costs of open and endovascular revascularisation to treat peripheral artery disease (PAD) have not been fully established. This study examined the costs of both the index admission and any readmissions to hospital within 30 days of discharge for people having revascularisation at a single centre in Australia.

Methods: This was a retrospective analysis of prospectively collected data. Eligible participants were those presenting with chronic limb ischaemia requiring revascularisation between 2002 and 2017. Generalised linear modelling was used to estimate mean (95% confidence interval [95% CI]) hospital costs for the index and readmission hospital treatments.

Results: A total of 302 participants presenting with intermittent claudication (n=219; 72.5%) or chronic limb threatening ischaemia (n=83; 27.5%) treated by open (n=116; 38.4%) or endovascular (n=186; 61.6%) revascularisation were included. Forty-eight (48) (15.9%) participants were readmitted within 30 days of discharge from their index admission. The mean estimated index admission hospital cost was AUD$13,827 (95% CI, $11,935–$15,818) per person. This cost was significantly greater for open as compared to endovascular revascularisation (p<0.001). The mean estimated hospital cost was AUD$15,324 ($10,944–$19,966) per person readmitted. When comparing participants treated before and after 2010, the total hospital costs decreased, mainly due to decreased lengths of hospital stay for open procedures.

Conclusions: In this study the hospital costs were less for endovascular than open revascularisation of chronic limb ischaemia. Costs decreased over time. Readmission is an important contributor to the overall costs of peripheral revascularisation.

Item ID: 70098
Item Type: Article (Research - C1)
ISSN: 1444-2892
Keywords: Chronic limb ischaemia, Health care economics, Peripheral artery disease, Revascularisation procedures, Vascular surgery
Copyright Information: © 2021 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ).
Funders: James Cook University (JCU), National Health and Medical Research Council (NHMRC)
Projects and Grants: JCU SRIF scheme, NHMRC 1117061
Date Deposited: 22 Mar 2022 22:29
Downloads: Total: 1
More Statistics

Actions (Repository Staff Only)

Item Control Page Item Control Page